Creating a model to improve treatment for severe bleeding after trauma
Official title: Development of a multi-scale closed loop model for hemorrhagic shock: a platform to assess REBOA performance
Funded at Texas Engineering Experiment Station · NIH-11055517 · Data updated 2026-11-12
This study is working on a new computer model to help doctors better manage severe bleeding after injuries, using a technique called REBOA to control the bleeding and improve patient care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | June 10, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $596,743 |
| NIH project number | 7R01HL162633-03 |
| Project ID | NIH-11055517 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have suffered traumatic injuries leading to hemorrhagic shock, particularly in military or emergency settings.
✕Less likely to help
Patients with non-traumatic causes of bleeding or those who are not experiencing hemorrhagic shock may not benefit from this research.
What this research studies
This research focuses on developing a new computational model to better understand and manage hemorrhagic shock, a critical condition that can occur after traumatic injuries. By simulating the body's physiological responses to severe bleeding, the study aims to optimize the use of a technique called Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), which helps control bleeding in emergency situations. The model will help identify the best practices for using REBOA, including the size and timing of balloon inflation, to minimize complications and improve patient outcomes. This innovative approach seeks to accelerate advancements in treatment without relying solely on costly animal studies.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better recovery outcomes for patients experiencing severe traumatic bleeding.
How similar studies have gone: While the use of computational models in medical research is gaining traction, this specific approach to optimizing REBOA is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
-
Texas Engineering Experiment Station
College Station, United States Active
Researchers
- Principal investigator: Rahbar, Elaheh — Texas Engineering Experiment Station
- Study coordinator: Rahbar, Elaheh
Related research
Other NIH-funded projects on the same topics.
-
Pragmatic midodrine trial to reduce ICU vasopressor use in septic shock
A practical, patient-focused trial tests whether taking oral midodrine can lessen the need for IV vasopressors and shorten ICU stays for people with sepsis-related low blood pressure.
-
Understanding how small heat shock proteins protect our cells
A study from the University of Washington explores how tiny chaperone proteins protect eye and other cells from damage, which could help prevent conditions like cataracts and age-related macular degeneration.
-
A new approach to freeing HIV from brain cells and reducing brain inflammation
A patient-focused approach tests a strategy to flush out hidden HIV in the brain and protect brain health by reducing inflammation.
-
Shock patients: better, faster teamwork to find the cause
A team of clinicians works together to quickly identify the exact cause of a patient’s shock to guide the right treatment.
-
Multi-scale model to improve REBOA use in hemorrhagic shock
A researcher team is building a computer model to better predict how to use REBOA, a device that can control bleeding in the torso, so patients with severe trauma may survive.
-
Phospholipid nanoparticle fluid to replace blood volume and protect organs in severe bleeding
A new, bubble-free fluid made of tiny lipid particles is being developed to quickly restore blood volume and protect organs during severe bleeding when real blood isn’t available.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.